dalteparin has been researched along with Renal Artery Stenosis in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Izzedine, H | 1 |
| Cluzel, P | 1 |
| Deray, G | 1 |
1 other study available for dalteparin and Renal Artery Stenosis
| Article | Year |
|---|---|
Renal radiation-induced arterial stenosis.
Topics: Adult; Angioplasty, Balloon; Fibrinolytic Agents; Heparin, Low-Molecular-Weight; Hodgkin Disease; Hu | 2007 |